Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-08-10

Clinical Trial Update: Whole-body MRI for the Detection of Metastasis

View source ↗

Summary

A clinical trial evaluating whole-body MRI to detect metastasis in breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Breast Cancer, Metastases | Status: WITHDRAWN